Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Prevalence of genotypic drug resistance among a cohort of HIV-infected newborns.

Parker MM, Wade N, Lloyd RM Jr, Birkhead GS, Gallagher BK, Cheku B, Sullivan T, Taylor J.

J Acquir Immune Defic Syndr. 2003 Mar 1;32(3):292-7.

PMID:
12626889
2.

Perinatal acquisition of drug-resistant HIV-1 infection: mechanisms and long-term outcome.

Delaugerre C, Chaix ML, Blanche S, Warszawski J, Cornet D, Dollfus C, Schneider V, Burgard M, Faye A, Mandelbrot L, Tubiana R, Rouzioux C; ANRS French Perinatal Cohort..

Retrovirology. 2009 Sep 19;6:85. doi: 10.1186/1742-4690-6-85.

3.

Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART.

Saracino A, Gianotti N, Marangi M, Cibelli DC, Galli A, Punzi G, Monno L, Lazzarin A, Angarano G; Mutations, Salvage Study Group..

J Med Virol. 2008 Oct;80(10):1695-706. doi: 10.1002/jmv.21261.

PMID:
18712823
4.

[Prevalence of drug resistance mutations among antiretroviral drug-naive HIV-1-infected patients in China].

Si XF, Huang HL, Wei M, Guan Q, Song YH, Ma PF, Quan Y, Xing H, Shao YM.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2004 Dec;18(4):308-11. Chinese.

PMID:
15650776
5.

High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients.

Masciotra S, Garrido C, Youngpairoj AS, McNulty A, Zahonero N, Corral A, Heneine W, de Mendoza C, García-Lerma JG.

AIDS. 2007 Nov 30;21(18):2503-11.

PMID:
18025887
6.

Prevalence of genotypic resistance among antiretroviral drug-naive HIV-1-infected patients in Belgium.

Van Vaerenbergh K, Debaisieux L, De Cabooter N, Declercq C, Desmet K, Fransen K, Maes B, Marissens D, Miller K, Muyldermans G, Sprecher S, Stuyver L, Vaira D, Verhofstede C, Zissis G, Van Ranst M, De Clercq E, Desmyter J, Vandamme AM.

Antivir Ther. 2001 Mar;6(1):63-70.

PMID:
11417763
7.

Antiretroviral resistance mutations among pregnant human immunodeficiency virus type 1-infected women and their newborns in the United States: vertical transmission and clades.

Palumbo P, Holland B, Dobbs T, Pau CP, Luo CC, Abrams EJ, Nesheim S, Vink P, Respess R, Bulterys M; Perinatal AIDS Collaborative Transmission Studfy..

J Infect Dis. 2001 Nov 1;184(9):1120-6.

PMID:
11598834
8.

Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000-2004.

Babic DZ, Zelnikar M, Seme K, Vandamme AM, Snoeck J, Tomazic J, Vidmar L, Karner P, Poljak M.

Virus Res. 2006 Jun;118(1-2):156-63.

PMID:
16417938
9.

Drug-resistance mutations in antiretroviral-naïve patients with established HIV-1 infection in Mexico.

Escoto-Delgadillo M, Vázquez-Valls E, Ramírez-Rodríguez M, Corona-Nakamura A, Amaya-Tapia G, Quintero-Pérez N, Panduro-Cerda A, Torres-Mendoza BM.

HIV Med. 2005 Nov;6(6):403-9.

10.

Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.

Pariente N, Pernas M, de la Rosa R, Gómez-Mariano G, Fernández G, Rubio A, López M, Benito JM, López-Galíndez C, Leal M, Domingo E, Martinez MA, Mas A.

J Med Virol. 2004 Jul;73(3):350-61.

PMID:
15170628
11.

Genotypic resistance and HIV-1 subtype in Brazilian children on dual and triple combination therapy.

Machado ES, Lambert JS, Watson DC, Afonso AO, da Cunha SM, Nogueira SA, Caride E, Oliveira RH, Sill AM, DeVico A, Tanuri A.

J Clin Virol. 2004 May;30(1):24-31.

PMID:
15072750
12.

Analysis of HIV- type 1 protease and reverse transcriptase in Brazilian children failing highly active antiretroviral therapy (HAART).

Machado DM, Fernandes SC, Succi RC, Freire WS, Pannuti CS, Gouveia AB, Levi JE, Diaz RS.

Rev Inst Med Trop Sao Paulo. 2005 Jan-Feb;47(1):1-5.

13.

Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy.

Recsky MA, Brumme ZL, Chan KJ, Wynhoven B, Yip B, Dong WW, Heath KV, Montaner JS, Levy AR, Hogg RS, Harrigan PR.

J Infect Dis. 2004 Jul 15;190(2):285-92.

PMID:
15216463
14.

[Prevalence of antiretroviral drug genotypic resistance among HIV patients in Cuenca, Spain].

Rodriguez-Escudero MJ, Prada de Medio E, Rosa Herranz C, Martinez Medina MC, Franquelo Gutierrez R.

Rev Esp Quimioter. 2007 Jun;20(2):203-5. Spanish.

15.

Prevalence and risk factors associated with antiretroviral resistance in HIV-1-infected children.

Delaugerre C, Warszawski J, Chaix ML, Veber F, Macassa E, Buseyne F, Rouzioux C, Blanche S.

J Med Virol. 2007 Sep;79(9):1261-9.

PMID:
17607781
16.

The prevalence of resistance-associated mutations to protease and reverse transcriptase inhibitors in treatment-naïve (HIV1)-infected individuals in Casablanca, Morocco.

Bakhouch K, Oulad-Lahcen A, Bensghir R, Blaghen M, Elfilali KM, Ezzikouri S, Abidi O, Hassar M, Wakrim L.

J Infect Dev Ctries. 2009 Jun 1;3(5):380-91.

17.

[Primary antiretroviral drug resistance among patients diagnosed with HIV infection in Gran Canaria (Spain) between 2002 and 2005].

Sánchez Oñoro M, López MJ, Santana MA, Andés JM, Campelo FA.

Enferm Infecc Microbiol Clin. 2007 Aug-Sep;25(7):437-40. Spanish.

PMID:
17692211
18.

Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to zidovudine during gestation or postnatally and treated with didanosine or zidovudine in the first three months of life.

Kovacs A, Cowles MK, Britto P, Capparelli E, Fowler MG, Moye J, McIntosh K, Rathore MH, Pitt J, Husson RN.

Pediatr Infect Dis J. 2005 Jun;24(6):503-9.

PMID:
15933559
19.

Genotypic human immunodeficiency virus type 1 drug resistance in highly active antiretroviral therapy-treated children in Abidjan, Côte d'Ivoire.

Chaix ML, Rouet F, Kouakoussui KA, Laguide R, Fassinou P, Montcho C, Blanche S, Rouzioux C, Msellati P.

Pediatr Infect Dis J. 2005 Dec;24(12):1072-6.

PMID:
16371868
20.

Effect of perinatal short-course zidovudine on the clinical and virological manifestations of HIV-1 subtype E infection in infants.

Sutthent R, Chokephaibulkit K, Piyasujabul D, Vanprapa N, Roogpisuthipong A, Chaisilwatana P.

J Clin Virol. 2002 Jul;25(1):47-56.

PMID:
12126721

Supplemental Content

Support Center